Grey Street Capital »

Amgen shares owned by Grey Street Capital

Quarter-by-quarter ownership of Amgen (AMGN) shares owned by Grey Street Capital from 13F filings

Historical chart of Grey Street Capital investment in Amgen

Tip: Access up to 7 years of quarterly data

All positions including Amgen held by Grey Street Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amgen by Grey Street Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.6M 5.6k 284.32

More positions owned by Grey Street Capital

NVIDIA Corporation (NVDA)
Eli Lilly & Co. (LLY)
Accenture Plc Ireland Shs Class A (ACN)
Microsoft Corporation (MSFT)
Apple (AAPL)
Vertex Pharmaceuticals Incorporated (VRTX)
Meta Platforms Cl A (META)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Crowdstrike Hldgs Cl A (CRWD)
Adobe Systems Incorporated (ADBE)
Goldman Sachs (GS)
Agnico (AEM)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Grey Street Capital

Top funds holding Amgen

Vanguard Group
BlackRock
State Street Corporation
Morgan Stanley
PRIMECAP Management Company
Geode Capital Management
Charles Schwab Investment Management
Wells Fargo & Company
Bank of America Corporation
Goldman Sachs Group
Bank of New York Mellon
Royal Bank of Canada
Henderson Group
T. Rowe Price Associates
Reed Conner & Birdwell

View all funds holding Amgen